MedPath

Evaluate Safety and Efficacy of RV Forte Capsule as an immunomodulator in adult Covid 19 positive patients

Phase 2
Completed
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/10/028568
Lead Sponsor
RV New Vision Healthcare Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patients admitted with RT-PCR confirmed COVID-19 illness

Age > 18 & < 65 years of either sex

Mild to Moderately Covid 19 disease (NEWS score <= 8)

Signed informed consent must be obtained and documented according to AYUSH GCP, and

national/local regulations.

Exclusion Criteria

Pregnant women

Breastfeeding women

Requiring ICU admission at screening

Patients above 65 years of age and below 18 Years

Past History of MI, Epileptic episodes

Any other co-morbidity (uncontrolled diabetes, severe hypertension from subject history) which

is at critical stage at screening

Any other condition by which subject proves unfit from investigator perspective

Not giving consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o. of days required for negative PCR confirmatory test <br/ ><br>Change in clinical symptom presentation <br/ ><br>Clinical status expressed in percentage of subjects reporting each severity rating <br/ ><br>Changes in X ray <br/ ><br>Changes in inflammatory mediators like CRP, LDH and ferritinTimepoint: 10 days or negative PCR test for Covid 19 whichever is earlier
Secondary Outcome Measures
NameTimeMethod
Change in National Early Warning Score <br/ ><br>Hematological parameters like WBS, HB and platelet count etc. <br/ ><br>Requirement of admission to intensive care unit <br/ ><br>Reduced hospital duration <br/ ><br>Total days admitted to the hospital (difference between admission date and discharge date of index admission) <br/ ><br>Timepoint: 10 days or negative PCR test for Covid 19 whichever is earlier
© Copyright 2025. All Rights Reserved by MedPath